The Future of Distributed Power Generation: New technologies, changing economics and the impact of fuel cells
Distributed power generation undergoing significant change as disparate pools of capacity give way to the establishment of integrated local generation. While distributed generation can reduce network losses and improve network stability, there are still a number of barriers including network connection costs, the operation of net metering and in some cases the application of market liberalisation. Resolution of these issues and efficiency gains in conventional, advanced fuel cell and renewable technologies will eventually lead to easier and faster integration of distributed generation and significant growth in distributed generating capacity. ‘The Future of Distributed Power Generation’ is a new report published by Business Insights that examines key environmental and legislative issues and analyses the technologies, efficiency and economics of conventional fossil fuel and advanced distributed generation. This new report analyses how demand for distributed generation capacity is likely to change as concern over energy security and network stability grows.
RELATED REPORTS
The personal navigation market continues to grow rapidly in Europe and North America. Thefirst Personal Navigation Devices (PNDs), i.e. transferable devices with integrated GPSreceivers and digital maps primarily designed for car navigation, were introduced in 2003. InEurope, the PND segment achieve ...
U.S. retail sales of gourmet, specialty and premium foods and beverages are growing at much faster rates than those of the overall food and beverage industry, surging 10.9% to $59.0 billion in 2007 and posting a compound annual growth rate of 11.1% for the 2003-2007 period. Key market drivers inclu ...
With 69.5 million American adults devoted to the Evangelical lifestyle, the current and still-growing societal and monetary clout of this cohort is impossible to ignore. In 2006, household income among Evangelicals represented 28% of the national total, or $2.1 trillion, and products, services and ...
| Countries : USA
Out of pocket health care expenditures represent a rapidly growing burden for consumers, both in terms of their increasing size and the lack of financing options to available to address them. While finance companies have rushed to provide credit for discretionary medical expenses, few funding source ...
| Countries : USA
Renewable Energy Investment in the U.S. is the first research study to focus exclusively on the emerging renewable energy (RE) investment market in the United States, a vast and complex market in the process of rapid evolution. Four primary RE technology sectors are covered: solar power, wind powe ...
| Countries : USA
The dietary supplement market is facing a difficult time with significant shifts in consumer demographics, extensive negative media coverage and legislative changes. In Europe the recent adoption of health claim harmonization via Articles 13 and 14 will significantly impact the ability to market pro ...
As the GIT Market begins to feature increasingly high levels of generic competition, the focus of pharmaceutical R&D strategies has shifted towards new therapy areas such as Crohn’s disease and Irritable Bowel Syndrome (IBS). Although such shifts are becoming the driving force for market transform ...
The modulation of immune system activity is a required pharmacological intervention for many medical conditions, bearing particular importance in the treatment of autoimmune diseases and allergies and transplant procedures. With traditional immunomodulatory drugs continuing to exhibit limited effica ...
| Countries : USA
Drug developments in the US and EU are becoming increasingly expensive and time consuming, with new products typically requiring investment of over 4 years and $1billion from concept to commercialization. As a result, China has emerged as an increasingly attractive option for companies aiming to red ...
As the pharma industry continues to experience rising research costs, drug failures and low returns on investment, companies who are increasingly facing major patent expiries and scarcely populated late-stage pipelines have accelerated efforts to enhance the speed and efficiency of drug research. T ...
Related countries
reportlinker.com © Copyright 2009. All rights reserved